Election 2020: Potential Impacts Series - Healthcare & Life Sciences
Holland & Knight's experienced lobbyists and attorneys are focusing on the policy implications of the upcoming 2020 elections. The fifth program in this series focused on healthcare and life sciences.
Partner Michael Werner focused on issues affecting drug and biotech companies such as those relating to possible regulation of drug prices, Medicare and Medicaid reimbursement, and regulatory reforms.
Partner Lisa Hawke addressed the potential for major changes to the healthcare system and the Affordable Care Act following the election, impacts on our public health, emergency preparedness and safety-net systems resulting from COVID-19, and the effects of all of these possible changes on healthcare providers and patients.